1. Home
  2. TIVC vs ZVSA Comparison

TIVC vs ZVSA Comparison

Compare TIVC & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • ZVSA
  • Stock Information
  • Founded
  • TIVC 2016
  • ZVSA 2014
  • Country
  • TIVC United States
  • ZVSA United States
  • Employees
  • TIVC N/A
  • ZVSA N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • ZVSA Health Care
  • Exchange
  • TIVC Nasdaq
  • ZVSA Nasdaq
  • Market Cap
  • TIVC 2.1M
  • ZVSA 2.5M
  • IPO Year
  • TIVC 2021
  • ZVSA N/A
  • Fundamental
  • Price
  • TIVC $3.95
  • ZVSA $0.65
  • Analyst Decision
  • TIVC
  • ZVSA
  • Analyst Count
  • TIVC 0
  • ZVSA 0
  • Target Price
  • TIVC N/A
  • ZVSA N/A
  • AVG Volume (30 Days)
  • TIVC 50.7K
  • ZVSA 968.0K
  • Earning Date
  • TIVC 05-15-2025
  • ZVSA 06-17-2025
  • Dividend Yield
  • TIVC N/A
  • ZVSA N/A
  • EPS Growth
  • TIVC N/A
  • ZVSA N/A
  • EPS
  • TIVC N/A
  • ZVSA N/A
  • Revenue
  • TIVC $516,000.00
  • ZVSA N/A
  • Revenue This Year
  • TIVC N/A
  • ZVSA N/A
  • Revenue Next Year
  • TIVC N/A
  • ZVSA N/A
  • P/E Ratio
  • TIVC N/A
  • ZVSA N/A
  • Revenue Growth
  • TIVC N/A
  • ZVSA N/A
  • 52 Week Low
  • TIVC $2.43
  • ZVSA $0.47
  • 52 Week High
  • TIVC $16.08
  • ZVSA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 42.76
  • ZVSA 54.57
  • Support Level
  • TIVC $3.96
  • ZVSA $0.60
  • Resistance Level
  • TIVC $4.18
  • ZVSA $0.73
  • Average True Range (ATR)
  • TIVC 0.25
  • ZVSA 0.07
  • MACD
  • TIVC -0.02
  • ZVSA 0.02
  • Stochastic Oscillator
  • TIVC 10.84
  • ZVSA 64.83

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

Share on Social Networks: